Leidos Inc., Atlanta, Georgia, United States of America.
Immunization Services Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
PLoS One. 2019 Mar 7;14(3):e0213431. doi: 10.1371/journal.pone.0213431. eCollection 2019.
Very few studies have explored the associations between self-identified sexual orientation and comprehensive vaccination coverage. Most of the previous studies that reported health disparities among lesbian, gay and bisexual populations were not based on a nationally representative sample of U.S. adults, limiting the generalizability of the findings. Starting in 2013, the National Health Interview Survey (NHIS) included questions to ascertain the adult's self-identified sexual orientation that allowed national level vaccination estimation by sexual orientation. This study examined associations of self-reported vaccination coverage for selected vaccines among U.S. adults by their sexual orientation.
We analyzed combined data from 2013-2015 NHIS, a nationally representative probability-based health survey of the noninstitutionalized U.S. population ≥18 years. For vaccines other than influenza, weighted proportions were calculated. Influenza coverage was calculated using the Kaplan-Meier procedure. Multivariable logistic regression models were used to calculate adjusted prevalence differences for each vaccine overall and stratified by sexual orientation and to identify factors independently associated with vaccination.
Significant differences were observed by sexual orientation for self-reported receipt of human papillomavirus (HPV), hepatitis A (HepA), hepatitis B (HepB), and influenza vaccination. Bisexual females (51.6%) had higher HPV coverage than heterosexual females (40.2%). Gay males (40.3% and 53.6%, respectively) had higher HepA and HepB coverage than heterosexual males (25.4% and 32.6%, respectively). Bisexual females (33.9% and 58.5%, respectively) had higher HepA and HepB coverage than heterosexual females (23.5% and 38.4%, respectively) and higher HepB coverage than lesbian females (45.4%). Bisexual adults (34.1%) had lower influenza coverage than gay/lesbian (48.5%) and heterosexual adults (43.8%). Except for the association of having self-identified as gay/lesbian orientation with greater likelihood of HepA, HepB, and influenza vaccination, sexual orientation was not associated with higher or lower likelihood of vaccination. Health status or other behavioral characteristics studied had no consistent relationship with vaccination among all populations.
Differences were identified in vaccination coverage among the U.S. adult population by self-reported sexual orientation. This study is the first to assess associations of sexual orientation with a comprehensive list of vaccinations. Findings from this study can serve as a baseline for monitoring changes over time. All populations could benefit from improved vaccination.
很少有研究探讨自我认同的性取向与全面疫苗接种覆盖率之间的关系。 大多数先前报告同性恋、双性恋和双性人群健康差距的研究并非基于美国成年人的全国代表性样本,限制了研究结果的普遍性。 自 2013 年以来,国家健康访谈调查(NHIS)纳入了确定成年人自我认同性取向的问题,允许按性取向进行全国性疫苗接种估计。 本研究检查了美国成年人按性取向报告的选定疫苗接种覆盖率的关联。
我们分析了 2013-2015 年 NHIS 的合并数据,这是一项针对非机构化美国人口≥18 岁的全国代表性概率健康调查。 对于流感以外的疫苗,计算了加权比例。 使用 Kaplan-Meier 程序计算流感疫苗覆盖率。 使用多变量逻辑回归模型计算了每种疫苗的总体调整后患病率差异,并按性取向分层,并确定与疫苗接种独立相关的因素。
自我报告的人乳头瘤病毒(HPV)、甲型肝炎(HepA)、乙型肝炎(HepB)和流感疫苗接种率因性取向而异。 双性恋女性(51.6%)的 HPV 接种率高于异性恋女性(40.2%)。 男同性恋者(分别为 40.3%和 53.6%)的 HepA 和 HepB 接种率高于异性恋男性(分别为 25.4%和 32.6%)。 双性恋女性(分别为 33.9%和 58.5%)的 HepA 和 HepB 接种率均高于异性恋女性(分别为 23.5%和 38.4%),且 HepB 接种率高于女同性恋女性(45.4%)。 双性恋成年人(34.1%)的流感疫苗接种率低于男同性恋/女同性恋(48.5%)和异性恋成年人(43.8%)。 除了自我认同为男同性恋/女同性恋取向与更高的 HepA、HepB 和流感疫苗接种率相关外,性取向与更高或更低的疫苗接种率无关。 在所有人群中,健康状况或其他行为特征与疫苗接种均无一致关系。
按自我报告的性取向,美国成年人的疫苗接种覆盖率存在差异。 本研究首次评估了性取向与全面疫苗接种清单的关联。 本研究结果可以作为监测随时间变化的基线。 所有人群都可以从改善疫苗接种中受益。